Reliv Kalogris Foundation Dedicates Nutrition Center for Impoverished Children in the Philippines (amazon) (shopzilla)

Chesterfield, MO (PRWEB) August 12, 2013

The Reliv Kalogris Foundation today announced the completion of their latest building project: a nutrition center for impoverished children in Welfareville, a depressed area in Mandaluyong City, Philippines. The RKF, the charitable arm of Reliv International, Inc. (NASDAQ: RELV), raised funds for the project through last years annual Rally for the Mission at the 2012 Reliv International Conference.

Through the RKFs partnership with Mount Zion Church of the Firstborn (MZCF), this building will be used for the distribution of daily Reliv nutrition shakes, two hot meals per week, choir practice, worship services, day care, life skills training and as a clinic for visiting doctors. These nutrition centers enable the volunteers to offer more than just nutrition to the children, said R. Scott Montgomery, chairman of the Reliv Kalogris Foundation. They also provide resources to help the children experience opportunities otherwise out of their reach.

Related Blogs

    New SoySentials Video from Reliv Promotes Nutritional Approach to Womens Health (amazon) (shopzilla)

    Chesterfield, MO (PRWEB) May 29, 2013

    Reliv International, Inc. (NASDAQ: RELV) today announced the company has released its most recent video, Find Your Balance: SoySentials with LunaRich, for public viewing on YouTube. The video focuses on SoySentials

    Related Blogs

      Healthy Energy Shot 24K Becomes Ninth Reliv Product to Earn Patent (amazon) (shopzilla)

      Chesterfield, MO (PRWEB) July 26, 2013

      Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, this week announced that healthy energy shot 24K has earned a patent from the US government. Dr. Carl W. Hastings, Relivs chief scientific officer and creator of 24K, made the announcement as part of opening night at Relivs 25th Anniversary International Conference.

      This patent validates the work our R&D team put into making 24K unlike any other energy product on the market, Hastings said. 24K provides a healthy alternative to the high-caffeine, high-sugar energy shots that have become so prevalent in recent years. And with 24K, you not only get energy, but nutritional support for mental focus and stress relief as well.

      The patent for 24K comes two years after the product was first introduced and was named the Peoples Choice for Favorite New Consumer Product by the American Business Awards.

      Cracking the Fatigue Cycle

      Energy drinks have surged in popularity in recent years, and health advocates have expressed concern about the excessive amounts of caffeine found in most of these products. The U.S. Food and Drug Administration continues to investigate reports of illness, injury and even death of people who drank products marketed as energy drinks or energy shots. In June, the American Medical Association adopted a policy supporting a ban of the marketing of high stimulant/caffeine drinks to adolescents under the age of 18.

      Most popular energy products rely on caffeine and sugar to provide a quick jolt, Hastings said. But this can cause an unhealthy spike in heart rate and blood sugar, leading to an inevitable crash. Such stimulants only mask the symptoms of fatigue. 24K provides a healthy solution by addressing the underlying problem the fatigue cycle.

      Physical fatigue and mental fog go hand-in-hand, and stress is a leading contributor to both. Together, they make up the fatigue cycle. 24K delivers 24 active ingredients backed by clinical research to address all three factors. View healthy energy shot 24K’s ingredient list.

      24K becomes the ninth Reliv nutritional formula to earn a US patent, joining Reliv Classic

      Related Blogs

        Reliv Acquires Exclusive Rights to Superfood Lunasin (amazon) (shopzilla)

        CHESTERFIELD, MO (PRWEB) July 24, 2013

        Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today announced that it has entered into an exclusive license for the intellectual property of Soy Labs LLC related to the nutritional ingredient lunasin. Lunasin is a naturally occurring peptide research has identified as the key to many of soys documented health benefits, from cholesterol reduction to general cellular health. Learn more about the benefits of lunasin.

        The license covers an issued patent and several patent applications related to lunasin and soy-related peptides, proprietary information and manufacturing processes of Soy Labs. Further, the arrangement allows certain Soy Labs employees to join the Reliv corporate staff. The License Agreement is for a term covering the entire period of the basic patent and then provides for a full assignment of all of the technology rights to Reliv. Reliv will make minimum payments of $ 1,150,000 initially and additional minimum payments over a five year period totaling $ 850,000. In addition, Reliv will pay a royalty at varying rates over the term of the agreement.

        This is a major step for Reliv and elevates our company to a unique status in the nutrition industry, said Ryan Montgomery, Reliv president. For the first time we own an ingredient in its entirety, from the extraction process to the patented mechanisms of action within the body. And lunasin isnt just any ingredient; its the worlds first epigenetic superfood.

        How Lunasin Works

        Lunasin is the first nutritional compound identified to affect gene expression and promote optimal health at the epigenetic level. The epigenome, which literally means beyond the genome, is a higher level of complexity within the cell. It acts like a dimmer for lights, controlling which genes are used, when they are used and how much they are used.

        Lunasin can attach itself to the epigenome. As a result, it can increase expression of important genes needed for normal cell functioning and protect the cells from environmental damage once it occurs. More than 50 published papers from more than 25 research institutions demonstrate lunasins multiple health benefits. Learn more about lunasin and epigenetics.

        Weve always endeavored to remain on the cutting edge of nutrition science in formulating our products at Reliv. And with the acquisition of lunasin, we are now leading the industry in the budding field of nutritional epigenetics, said Dr. Carl W. Hastings, vice chairman and chief scientific officer.

        New research shows that through nutrition people can influence which genes are expressed, he added. Reliv is committed to building on this emerging science and developing nutritional solutions that help people take control of their health.

        Tremendous Opportunity

        Relivs license of the intellectual property behind Soy Labs lunasin production and marketing stems from a joint research and development partnership formed in August 2011 among Reliv, Soy Labs and the Missouri Plant Science Center. That partnership resulted in the creation of LunaRich

        Related Blogs

          Reliv Conference to Feature Presentation on Lunasin and Nutritional Epigenetics (amazon) (shopzilla)

          Chesterfield, MO (PRWEB) June 28, 2013

          Reliv International (NASDAQ: RELV) today announced that the companys 25th anniversary conference in Orlando on July 18-20 will include a presentation on nutritional epigenetics and the science behind the soy peptide lunasin. Presenters will include Dr. Carl Hastings, Reliv chief scientific officer, and Dr. Alfredo Galvez, research scientist at the Center of Excellence in Nutritional Genomics at UC Davis and lead scientific advisor at the Missouri Plant Science Center (MPSC).

          Hastings will discuss the importance of the joint biotechnology and development partnership between Reliv and the MPSC, the achievements of this partnership to date and its potential for further innovations in nutrition science.

          Galvez will present the latest lunasin research, describe the emergence of epigenetics as a new frontier in our understanding of human health and discuss the potential applications for nutritional epigenetics in the future of health care.

          Lunasin and Epigenetics

          Epigenetics is the study of changes in gene expression in cells caused by mechanisms other than changes in DNA. The epigenome, which literally means beyond the genome, is a higher level of complexity in the cell that determines which genes are used, when they are used and how much they are used. The epigenome is the reason why different types of cells eye cells, skin cells, liver cells can have the same DNA but perform vastly different functions.

          Lunasin is the first nutritional compound identified to promote optimal cellular health through an epigenetic mechanism of action. Lunasin attaches itself to the epigenome in the cell to increase expression of important genes needed for normal cell functioning and protect the cells from environmental damage once it occurs. Learn more about lunasin and epigenetics.

          LunaRich from Reliv


          Related Blogs

            Reliv International Announces Executive Promotions (amazon) (shopzilla)

            CHESTERFIELD, MO (PRWEB) June 06, 2013

            Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today announced that its Board of Directors has appointed Steve Hastings to the position of Executive Vice President of Sales & Marketing and Brett Hastings to the position of Senior Vice President and Chief Operating Officer. Steve Hastings had been serving as Relivs Senior Vice President of North American Sales, while Brett functioned as Relivs Vice President of Legal.

            In his new position, Steve Hastings will oversee sales development and marketing outreach for Reliv International, with a primary focus on US and Canada.

            Steve has been with Reliv for more than 20 years and has led some our most successful sales and marketing initiatives, said Reliv President Ryan Montgomery. He will continue to develop strategies and spearhead innovative projects moving forward, working with field leaders to increase sales. I am confident his leadership will help drive growth in the years to come.

            As COO, Brett Hastings will be responsible for the day-to-day operations at Reliv, including manufacturing, distributor services, IT, internal audit, purchasing and legal/compliance.

            Bretts work with legal has been exceptional, as has his work since assuming leadership of manufacturing in 2011, Montgomery said. He increased operational efficiencies, oversaw the flawless integration of LunaRich

            Related Blogs

              Reliv International Opens in France (amazon) (shopzilla)

              CHESTERFIELD, MO (PRWEB) March 31, 2013

              Reliv International (NASDAQ: RELV) today announced that it has officially opened in France. The event celebrating this milestone will take place April 12-13 in Paris at the Novotel Pont de Sevres. France becomes the nutritional supplement manufacturers sixth country of operation in Europe and 16th overall.

              Our business in Europe is booming, and France is a big part of that, said Ryan Montgomery, Reliv President. Reliv Europe has recorded five straight years of sustained growth and shows no signs of slowing down. Making France our 16th country of operation will provide added opportunities, momentum and increased operational efficiencies.

              Explosive Growth

              Relivs net sales in Europe jumped 72.7% from 2011 to 2012 after climbing 80.4% the previous year. The number of Reliv distributors in Europe mirrors that sales growth, increasing 77.4% from 2010 to 2011 and then 79.7% from 2011 to 2012.

              Europe is our hottest market and we are committed to fostering continued expansion in the region, added Montgomery. We have invested in staffing and infrastructure in Europe, including a new office and warehouse, in anticipation of continued growth.

              Celebrating Success

              Reliv will mark the occasion with a special event open to all on April 12-13 featuring Montgomery, Reliv Europe Managing Director Eric Vill and leading distributors from throughout Europe. The event will start with a Reliv business opportunity meeting at 7:30pm Friday night followed by a full days agenda starting at 9:30am on Saturday that includes workshops, guest speakers and special presentations.

              This is an event not to be missed for anyone looking for a solution in these challenging times, Vill said. Reliv offers what people today need most: better health and financial freedom. Thats why Relivs business opportunity is exploding in Europe right now. I encourage you to attend this event or look us up online to learn how Reliv can help you lead a better life starting today.

              The Paris event is one of several around the world this year celebrating Relivs 25 years in business, all culminating with the Reliv 25 International Conference in Orlando on July 18-20.

              About Reliv International, Inc.

              Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women’s health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich

              Related Blogs

                Reliv Launches Most Potent Form of Lunasin Ever Produced (amazon) (shopzilla)

                CHESTERFIELD, MO (PRWEB) January 17, 2013

                Reliv International (NASDAQ: RELV) has launched LunaRich X, the most pure, concentrated form of lunasin ever produced. Lunasin is a naturally occurring peptide scientists have identified as responsible for many of soys documented health benefits, including cholesterol reduction and general cellular health.

                In February 2012 Reliv introduced LunaRich

                Related Blogs

                  Subscribe By Email for Weekly Updates.